..."/>

Upcoming Patient Webinars Will Bring the Science to YOU

Fight Colorectal Cancer is giving you the opportunity to talk to researchers and medical professionals in April and May through online webinars designed to bring the science of treating colorectal cancer down to the personal.

The latest news from the petri dish
Wednesday, April 20, 2011
8 – 9 PM Eastern

Dr. Yaeger at work in her lab

Dr. Rona Yaeger will discuss the research she has been conducting over the past year with the grant she received as part of Fight Colorectal Cancer’s Lisa Fund research program.

Dr. Yaeger’s research focused on inhibiting the AKT pathway in colorectal cancer cells. She conducted basic research to determine how inhibitors to the pathway might affect cells of patients who have mutated KRAS and are resistant to EGFR inhibiting drugs. Dr. Yaeger has also been conducting a phase II clinical trial with an AKT inhibitor for patients with metastatic colorectal cancer who have normal (wild type) KRAS.

If you are interested in learning more about the future of cancer treatments, or if you’ve ever donated to the Fight Colorectal Cancer Lisa Fund, do not miss this webinar!

Personalizing personalized medicine
Monday, April 25, 2011
8 – 9 PM Eastern

Carolyn Grande, CRNP, AOCNP

Oncology nurse practitioner Carolyn Grande will make personalized medicine a little more personal during this webinar. If you’ve ever heard your doctor mention “tumor markers,” “biomarkers,” “KRAS”, “BRAF,” or “tumor pathways” and wondered what he or she meant, this webinar is for you. In fact, Carolyn may even be able to explain why Rona Yaeger’s pathway research (above) could mean big answers for colorectal cancer patients some day.

Carolyn is a member of Fight Colorectal Cancer’s Medical Advisory Board. In March, she presented this information to the advocates who participated in our Call-on Congress. Her presentation was so popular, we asked and she graciously agreed to make it a part of our webinar program. Don’t miss out!

Treating liver mets
Monday, May 16, 2011

8 – 9 PM Eastern

Dr. Andrew Kennedy

The liver is usually the first place where colorectal cancer metastasizes, so learning to manage tumors in the liver can help stage IV patients survive longer. Fortunately, liver directed therapies have evolved over the last two decades so patients with metastatic or primary liver tumors now have many new treatment options.

We are pleased that one of the leading researchers on liver metastases in the country has agreed to speak about these new options with us and our webinar participants. Join Dr. Andrew Kennedy and learn about how you may be impacted by these new discoveries. Register today.

Don’t worry if you’ve missed some of our webinars.

We archive them! You can watch and listen to the following patient webinars any time (in descending chronological order):

Related posts

*

*


− five = 1

Top